Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 2453323-79-8 | MDL No. : | N/A |
Formula : | C7H15ClN2O | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | YCSZOLSBNZXKAS-UHFFFAOYSA-N |
M.W : | 178.66 | Pubchem ID : | 145711667 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.86 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 46.55 |
TPSA : | 32.34 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -7.06 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 0.47 |
Log Po/w (WLOGP) : | 0.57 |
Log Po/w (MLOGP) : | 0.28 |
Log Po/w (SILICOS-IT) : | 0.16 |
Consensus Log Po/w : | 0.29 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.05 |
Solubility : | 16.1 mg/ml ; 0.09 mol/l |
Class : | Very soluble |
Log S (Ali) : | -0.72 |
Solubility : | 34.2 mg/ml ; 0.191 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -1.17 |
Solubility : | 12.0 mg/ml ; 0.0673 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.18 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P264-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P332+P313-P337+P313-P362-P403+P233-P405-P501 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
A527499[ 1956382-44-7 ]
N,N-Dimethyl-1-(methylamino)cyclopropanecarboxamide
Reason: Free-salt
[ 1956382-44-7 ]
N,N-Dimethyl-1-(methylamino)cyclopropanecarboxamide
Similarity: 0.98
[ 176445-81-1 ]
1-(Dimethylamino)cyclopropanecarboxamide
Similarity: 0.90
[ 1220031-46-8 ]
2-Amino-N-cyclohexyl-N,2-dimethylpropanamide hydrochloride
Similarity: 0.86
[ 1956382-44-7 ]
N,N-Dimethyl-1-(methylamino)cyclopropanecarboxamide
Similarity: 0.98
[ 176445-81-1 ]
1-(Dimethylamino)cyclopropanecarboxamide
Similarity: 0.90
[ 1956382-44-7 ]
N,N-Dimethyl-1-(methylamino)cyclopropanecarboxamide
Similarity: 0.98
[ 1481463-48-2 ]
1-Amino-N,N-dimethylcyclopropane-1-carboxamide
Similarity: 0.93
[ 176039-45-5 ]
(R)-2,3-Dimethyl-2-(N-methylacetamido)butanamide
Similarity: 0.91
[ 1956382-44-7 ]
N,N-Dimethyl-1-(methylamino)cyclopropanecarboxamide
Similarity: 0.98
[ 1481463-48-2 ]
1-Amino-N,N-dimethylcyclopropane-1-carboxamide
Similarity: 0.93
[ 1956382-44-7 ]
N,N-Dimethyl-1-(methylamino)cyclopropanecarboxamide
Similarity: 0.98
[ 176039-45-5 ]
(R)-2,3-Dimethyl-2-(N-methylacetamido)butanamide
Similarity: 0.91
[ 176445-81-1 ]
1-(Dimethylamino)cyclopropanecarboxamide
Similarity: 0.90
[ 1956382-44-7 ]
N,N-Dimethyl-1-(methylamino)cyclopropanecarboxamide
Similarity: 0.98
[ 176039-45-5 ]
(R)-2,3-Dimethyl-2-(N-methylacetamido)butanamide
Similarity: 0.91